Prognostic value of CD4<sup>+</sup> in patients with Т1-2N0M0 breast cancer
Aim. To evaluate the prognostic value of CD4+ in patients with T1-2N0M0 breast cancer.Materials and methods. We performed a quantitative assessment of CD4+ T-lymphocytes in tumor stromal cells and determined the prognostic parameter using the method developed by us (patent No. RU2697709C1 dated 19.0...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Book |
| Published: |
ABV-press,
2023-08-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Connect to this object online.3rd Floor Main Library
| Call Number: |
A1234.567 |
|---|---|
| Copy 1 | Available |